Slides: Expert Insight on Practice Changing Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers
Download these slides from David Scott Miller, MD, FACOG, FACS, and Linda Duska, MD, MPH, with key data for gynecologic cancers presented at the 2023 SGO annual meeting, including practice changing results for novel agents in ovarian and endometrial cancers, and practical insights on recent approvals for cervical cancer.
Gynecologic Oncologist Department of OB GYN/Gynecologic Oncology University of Virginia School of Medicine Charlottesville, Virginia
David Scott Miller, MD, FACOG, FACS
Amy and Vernon E. Faulconer Distinguished Chair in Medical Science Director and Dallas Foundation Chair in Gynecologic Oncology Professor of Obstetrics & Gynecology Fred F. Florence Bioinformation Center University of Texas Southwestern Medical Center Medical Director of Gynecologic Oncology Chair,Cancer Committee Parkland Health & Hospital System Dallas, Texas
Provided by Clinical Care Options (CCO)
Supported by educational grants from AstraZeneca, Genmab, GlaxoSmithKline, Merck Sharp & Dohme Corp., Novocure Inc., and Seagen Inc.
Merck Sharp & Dohme Corp.
Select date of attendance
Welcome to the CCO site
Thank you for your interest in CCO content. As a guest, please complete the following information. This data helps ensure our continued delivery of impactful medical education.
You will be sent to the previous page if you close this window.